09022833777
Sections
Search
Subscribe
DealCurry
Equity
Venture Capital
Private Equity
M&A

Mergers & Acquisitions | 29 June 2012

Bliss GVS Acquires Majority Stake In Kremoint Pharma

by Paritosh Gajjar
Bliss GVS Acquires Majority Stake In Kremoint Pharma
Share on Social Media Email Facebook Twitter Linkedin
 
@Paritosh

@Bliss_GVS has acquired 70% management stake in @Kremoint Private Limited, a BSE filing stated. The amount of investment is not disclosed.

The acquisition is aimed at boosting the company's manufacturing and export of pharmaceuticals.

Kremoint Pharma, commenced manufacturing operations in 1994 under Ashwin.K.Thakkar and is a manufacturer, exporter and supplier of various types of ointments and cream and gel formulations which includes antibiotics, corticosteroids, antiseptic and anti-inflammatory type of combinations. It exports its various pharmaceutical formulations to countries like Congo, Nairobi, Dubai and Nigeria.

TA Associate To Acquire Stake In Healthcare BPO-Omega

TA Associate To Acquire Stake In Healthcare BPO-Omega

TA Associate is acquiring a controlling stake in Omega Healthcare Management Services, a healthcare BPO for R530Cr.

Read More...

Zoomcar Secures Funding From Sequoia Capital, Others

Zoomcar Secures Funding From Sequoia Capital, Others

Bangalore based ZoomCar India Private Limited, a self-driven car rental startup, has raised $8 Mn in new round of funding led by Sequoia Capital India. Other investors include former Infosys CFO Mohandas Pai and Manipal Group's head of corporate affairs Abhay Jain.

Read More...
DealCurry Timeline
TL Home Search New Keet
CONTACT US
Info@DealCurry.com
09022833777
A 314, 3rd Floor, AntopHill Warehousing Company,
Near Dosti Acres
Wadala(E),
Mumbai 400037
 
   
 
CLIENTS
USEFUL LINKS
SOLUTIONS
Copyright © EagleEye Research & Media Pvt. Ltd. 2009 All Rights Reserved - Interactive multimedia analysis platform for financial markets.
Site map |Terms of Use |Privacy Policy
DealCurry tracks financial and corporate markets for events, interprets and integrates the information in our platform, providing premium data, news and analytics. DealCurry provides comprehensive coverage of the capital markets through an intuitive, user-friendly interface.